Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
Netanyahu on Gush Etzion terror attack: 'We will complete war on all fronts'- CVS forecasts 2026 profit above estimates on strong performance
- Interoceanic Train derails in southern Mexico, injuring at least 15 and halting traffic on line
- How Would You Like to Deal with Your Funds?
- We analyzed Philly street scenes and identified signs of gentrification using machine learning trained on longtime residents’ observations
- Israeli naval intelligence reduces Iranian threat to Strait of Hormuz
- NASA, in a rare move, cuts space station mission short after an astronaut's medical issue
- Taylor Swift's 'The End of an Era' docuseries: Everything you need to know, plus how to watch for less
- NASA begins the countdown for humanity's first launch to the moon in 53 years
